Search filters

List of works by Theodosios D. Filippatos

A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia

scientific article published on 01 July 2007

A Review of Time Courses and Predictors of Lipid Changes with Fenofibric Acid-Statin Combination ⬇️

scientific article published on June 1, 2012

A review of the metabolic effects of sibutramine.

scientific article

A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease.

scientific article published on 02 February 2012

Acid-base and electrolyte disorders associated with the use of antidiabetic drugs.

scientific article

Adverse Effects of GLP-1 Receptor Agonists

scientific article (publication date: 2014)

Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome.

scientific article published on 28 October 2008

Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?

scientific article published on 29 September 2017

Analysis of 6-month effect of orlistat administration, alone or in combination with fenofibrate, on triglyceride-rich lipoprotein metabolism in overweight and obese patients with metabolic syndrome

scientific article published on 13 June 2008

Apolipoprotein CIII and diabetes. Is there a link?

scientific article published on 07 January 2019

Are lower levels of LDL-cholesterol really better? Looking at the results of IMPROVE-IT: opinions of three experts - III

scientific article published in January 2015

Cholesteryl ester transfer protein inhibitors: challenges and perspectives

scientific article published on 12 May 2016

Combination drug treatment in obese diabetic patients ⬇️

scientific article published on March 15, 2010

Combination drug treatment in patients with non-alcoholic fatty liver disease

scientific article published on April 2010

Combination of fenofibrate with non-statin drug regimens.

scientific article published on October 2010

Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria

scientific article published on 01 July 2006

Correction of hypovolemia with crystalloid fluids: Individualizing infusion therapy.

scientific article published on 26 March 2015

Current lipid-modifying agents

scientific article published on 06 April 2015

Dapagliflozin in patients with type 2 diabetes mellitus.

scientific article

Differences in metabolic parameters and cardiovascular risk between American Diabetes Association and World Health Organization definition of impaired fasting glucose in European Caucasian subjects: a cross-sectional study.

scientific article published on October 2013

Differential pharmacology and clinical utility of dapagliflozin in type 2 diabetes

scientific article published on 19 September 2019

Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?

scientific article

Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia.

scientific article published in March 2009

Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemia

Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study

scientific article published in December 2005

Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study

Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia.

scientific article published on 2 October 2007

Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study

scientific article published on 14 January 2013

Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and Diabetes

scientific article published on 03 March 2019

Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables.

scientific article

Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritis

scientific article published on 25 June 2009

Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women

scientific article published on 10 October 2007

Effects of ezetimibe, either alone or in combination with atorvastatin, on serum visfatin levels: a pilot study

scientific article published in August 2008

Effects of ezetimibe/simvastatin combination on metabolic parameters.

scientific article

Effects of glucagon-like peptide-1 receptor agonists on renal function

scientific article published on October 2013

Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study.

scientific article published on 13 June 2007

Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients

scientific article published in July 2008

Effects of sodium-glucose co-transporter 2 inhibitors on metabolism: unanswered questions and controversies

scientific article published on 6 November 2016

Electrolyte disorders associated with the use of anticancer drugs

scientific article published on 29 February 2016

Emerging Fixed-Dose Combination Treatments for Hyperlipidemia

scientific article published on 25 March 2019

Evaluation and treatment of hypernatremia: a practical guide for physicians

scientific article published on 27 January 2016

Excess body weight and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects.

scientific article published in July 2007

Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia

scientific article published on 08 July 2011

High density lipoprotein and cardiovascular diseases.

scientific article published on July 2013

High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemia

scientific article published on 15 February 2011

Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in women.

scientific article published in March 2008

Hypolipidemic Drugs and Diabetes Mellitus-Mechanisms and Data From Genetic Trials.

scientific article

Hyponatremia in patients with heart failure

scientific article published on 01 September 2013

Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromise

scientific article published on 21 June 2016

Hyponatremia in the elderly: challenges and solutions

scientific article

Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile.

scientific article published on 2 October 2011

Increased plasma visfatin levels in subjects with the metabolic syndrome

scientific article published on 01 January 2008

Leptospirosis is associated with markedly increased triglycerides and small dense low-density lipoprotein and decreased high-density lipoprotein.

scientific article published on 19 June 2011

Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma

scientific article

MANAGEMENT OF ENDOCRINE DISEASE: Hypothyroidism-associated hyponatremia: mechanisms, implications and treatment

scientific article

Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitors.

scientific article

Mediterranean Diet and 10-year (2002-2012) Incidence of Diabetes and Cardiovascular Disease in Participants with Prediabetes: The ATTICA study

scientific article published in January 2016

Modeling anthropometric indices in relation to 10-year (2002-2012) incidence of cardiovascular disease, among apparently healthy individuals: The ATTICA study

scientific article published on 03 June 2017

Obesity and arterial compliance alterations

scientific article published in March 2010

Pathophysiology of Diabetic Dyslipidaemia

scientific article published on 31 January 2017

Pharmacokinetic drug evaluation of empagliflozin plus linagliptin for the treatment of type 2 diabetes.

scientific article

Pharmacological management of diabetic dyslipidemia

scientific article published on 19 November 2016

Pharmacological management of hyponatremia

scientific article published on 02 August 2018

Pitavastatin and carbohydrate metabolism: what is the evidence?

scientific article

Plasma triglyceride levels and body mass index values are the most important determinants of prebeta-1 HDL concentrations in patients with various types of primary dyslipidemia

scientific article published on 25 July 2009

Recommendations for severe hypertriglyceridemia treatment, are there new strategies?

scientific article published in January 2014

Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption Inhibition

scientific article published on 7 October 2016

Review article: effects of plant sterols and stanols beyond low-density lipoprotein cholesterol lowering.

scientific article published on 03 March 2010

Role of ezetimibe in non-alcoholic fatty liver disease.

scientific article

SGLT-2 inhibitors: pharmacokinetics characteristics and effects on lipids

scientific article published on 31 October 2018

SGLT2 inhibitors and the kidney: Effects and mechanisms

scientific article published on 06 June 2018

SGLT2 inhibitors: are they safe?

scientific article published on 17 October 2017

Safety considerations with fenofibrate/simvastatin combination.

scientific article published on July 2015

Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individuals.

scientific article

Small high-density lipoprotein (HDL) subclasses are increased with decreased activity of HDL-associated phospholipase A₂ in subjects with prediabetes.

scientific article published on 2 April 2013

Starting with rosuvastatin in primary hyperlipidemia--Is there more than lipid lowering?

scientific article

Statin-Ezetimibe Combination Therapy In Diabetic Individuals

scientific article published on 14 August 2015

Ten common pitfalls in the evaluation of patients with hyponatremia

scientific article

Ten pitfalls in the proper management of patients with hyponatremia

scientific article published on 6 May 2016

The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia

scientific article published on 29 May 2008

The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome

scientific article published on 05 September 2006

The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia

scientific article published on 01 December 2008

The effects of ezetimibe and/or orlistat on triglyceride-rich lipoprotein metabolism in obese hypercholesterolemic patients.

scientific article published on 9 April 2010

The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome

scientific article published on 24 April 2007

The effects of orlistat on metabolic parameters and other cardiovascular risk factors.

scientific article

The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia

scientific article published on 29 June 2011

The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol

scientific article published on 01 July 2006

The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected].

scientific article published on 19 April 2014

The safety of ezetimibe and simvastatin combination for the treatment of hypercholesterolemia

scientific article published on 21 February 2016

Thiazide-associated hyponatremia in the elderly: what the clinician needs to know

scientific article

Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study)

scientific article published on 01 June 2006

Treatment of hyperlipidaemia with fenofibrate and related fibrates

scientific article published in October 2008

Treatment of hyponatremia: the role of lixivaptan

scientific article published on 28 April 2014

Use of intravenous fluids/solutions: a narrative review

scientific article published on 16 November 2016

Visfatin/PBEF and atherosclerosis-related diseases

scientific article published on 01 January 2010

Paulina is supported by:

About Paulina

Help